AGIG

Such option was received as compensation for the reporting person's services as a member of the board of directors of the issuer and its exercise is subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such option and the shares of common stock issuable upon exercise thereof until its issuance pursuant to the issuer's 2025 Equity Incentive Plan.

Such option was received as compensation for the reporting person's services as a member of the board of directors of the issuer and its exercise is subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such option and the shares of common stock issuable upon exercise thereof until its issuance pursuant to the issuer's 2025 Equity Incentive Plan.

Such option was received as compensation for the reporting person's services as a member of the board of directors of the issuer and its exercise is subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such option and the shares of common stock issuable upon exercise thereof until its issuance pursuant to the issuer's 2025 Equity Incentive Plan.

Such option was received as compensation for the reporting person's services as a member of the board of directors of the issuer and its exercise is subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such option and the shares of common stock issuable upon exercise thereof until its issuance pursuant to the issuer's 2025 Equity Incentive Plan.

Open market purchase by the reporting person of 11,000 shares of common stock, par value $0.001 per share.

Open market purchase by the reporting person of 14,990 shares of common stock, par value $0.001 per share.

Open market purchase by the reporting person of 13,000 shares of Common Stock.

Open market purchase by the reporting person of 10,000 shares of Common Stock.

Open market purchase by the reporting person of 1,050 shares of common stock, par value $0.001 per share (the "Common Stock").

Open market purchase by the reporting person of 10,000 shares of common stock, par value $0.001 per share.

Open market purchase by the reporting person of 8,950 shares of Common Stock.

Open market purchase by the reporting person of 8,220 shares of common stock, par value $0.001 per share (the "Common Stock").

Reflects the weighted average price of the shares purchased on the open market in multiple transactions on May 12, 2026 at prices ranging from $1.18 to $1.189 per share, inclusive.

The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of such shares of Common Stock purchased at each separate price within such range.

Such shares of common stock were received as compensation for the reporting person's services as a member of the board of directors of the issuer and are subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such shares until their issuance pursuant to the issuer's 2025 Equity Incentive Plan.

Such option was received as compensation for the reporting person's services as a member of the board of directors of the issuer and its exercise is subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such option and the shares of common stock issuable upon exercise thereof until its issuance pursuant to the issuer's 2025 Equity Incentive Plan.

Such shares of common stock were received as compensation for the reporting person's services as a member of the board of directors of the issuer and are subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such shares until their issuance pursuant to the issuer's 2025 Equity Incentive Plan.

Such shares of common stock were received as compensation for the reporting person's services as a member of the board of directors of the issuer and are subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such shares until their issuance pursuant to the issuer's 2025 Equity Incentive Plan.

Such shares of common stock were received as compensation for the reporting person's services as an executive officer of the issuer and are subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such shares until their issuance pursuant to the issuer's 2025 Equity Incentive Plan.

Such shares of common stock were received as compensation for the reporting person's services as a member of the board of directors of the issuer and are subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such shares until their issuance pursuant to the issuer's 2025 Equity Incentive Plan.

Such option was received as compensation for the reporting person's services as a member of the board of directors of the issuer and its exercise is subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such option and the shares of common stock issuable upon exercise thereof until its issuance pursuant to the issuer's 2025 Equity Incentive Plan.

Such shares of common stock were received as compensation for the reporting person's services as an executive officer of the issuer and are subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such shares until their issuance pursuant to the issuer's 2025 Equity Incentive Plan.

Such shares of common stock were received as compensation for the reporting person's services as an executive officer and member of the board of directors of the issuer and are subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such shares until their issuance pursuant to the issuer's 2025 Equity Incentive Plan.

Open market purchase by the reporting person of 12,500 shares of common stock, par value $0.001 per share (the "Common Stock").

Reflects the weighted average price of the shares purchased on the open market in multiple transactions on December 23, 2025 at prices ranging from $1.85 to $1.96 per share, inclusive.

The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of such shares of Common Stock purchased at each separate price within such range.

Open market purchase by the reporting person of 30,000 shares of Common Stock.

The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of such shares of Common Stock purchased at each separate price within such range.

Reflects the weighted average price of the shares of Common Stock purchased on the open market in multiple transactions on December 22, 2025 at prices ranging from $1.76 to $1.94 per share, inclusive.

Open market purchase by the reporting person of 9,500 shares of common stock, par value $0.001 per share.

Open market purchase by the reporting person of 8,461 shares of common stock, par value $0.001 per share (the "Common Stock").

Reflects the weighted average price of the shares purchased on the open market in multiple transactions on December 19, 2025 at prices ranging from $1.60 to $1.72 per share, inclusive.

The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of such shares of Common Stock purchased at each separate price within such range.

The Reporting Person exchanged all of its units of Abundia Global Impact Group, LLC in exchange for the indicated shares of common stock, par value $0.001, of Houston American Energy Corp. ("HUSA") pursuant to the Share Exchange Agreement, dated February 20, 2025, by and among the HUSA, Abundia Financial LLC and the Reporting Person, as amended.

The Reporting Person exchanged all of its units of Abundia Global Impact Group, LLC in exchange for the indicated shares of common stock, par value $0.001, of Houston American Energy Corp. ("HUSA") pursuant to the Share Exchange Agreement, dated February 20, 2025, by and among the HUSA, Abundia Financial LLC and the Reporting Person, as amended.

This amended Form 4 is being filed to correct the amount reported in Item 5 of Table I of the Reporting Person's original Form 4, filed on July 3, 2025, to account for the 10-to-1 reverse stock split effected by HUSA on June 6, 2025.

This Form 4 amendment is being filed by the reporting person in order to correct the transaction date in the Form 4 filed by the reporting person with the U.S. Securities and Exchange Commission ("SEC") on July 1, 2025 (the "Original Form 4"). On June 27, 2025, the board of directors of the issuer approved the grant of the shares of the issuer's common stock, par value $0.001 per share (the "Common Stock"), reported in the Original Form 4. Accordingly, the date in Column 2 of the Original Form 4 is hereby amended to June 27, 2025.

This Form 4 amendment is also being filed by the reporting person in order to correct the total number of shares of Common Stock beneficially owned and reported in the Original Form 4, which erroneously included 11,917.48 shares of Common Stock issuable upon exercise of stock options previously awarded to the reporting person and reported in Table II of the Form 4 filed by the reporting person with the SEC on June 17, 2025. Accordingly, the number of shares of Common Stock reported in Column 5 of Table I of the Original Form 4 is hereby amended to 40,000 shares of Common Stock.

This Form 4 amendment is being filed by the reporting person in order to correct the transaction date in the Form 4 filed by the reporting person with the U.S. Securities and Exchange Commission ("SEC") on July 1, 2025 (the "Original Form 4"). On June 27, 2025, the board of directors of the issuer approved the grant of the shares of the issuer's common stock, par value $0.001 per share (the "Common Stock"), reported in the Original Form 4. Accordingly, the date in Column 2 of the Original Form 4 is hereby amended to June 27, 2025.

This Form 4 amendment is also being filed by the reporting person in order to correct the total number of shares of Common Stock beneficially owned and reported in the Original Form 4, which erroneously included 1,500 shares of Common Stock issuable upon exercise of stock options previously awarded to the reporting person and reported in Table II of the Form 4 filed by the reporting person with the SEC on January 17, 2025, on a pre-reverse stock split basis. Accordingly, the number of shares of Common Stock reported in Column 5 of Table I of the Original Form 4 is hereby amended to 56,000 shares of Common Stock

On June 17, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $10.60 per share (the trading price for the last business day before the grant date). Therefore, on June 17, 2025, 1,415.09 options were granted to the reporting person.

The options were granted on June 17, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

Reflects the 10-for-1 reverse stock split effected by the Company which became market effective on June 9, 2025.

On May 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $0.68 per share (the trading price for the last business day before the grant date). Therefore, on May 15, 2025, 22,058.82 options were granted to the reporting person. Since the date of issue, the Company effected a 10-for-1 reverse stock split which became market effective on June 9, 2025. The number of options initially issued was 10 times more than the number set forth in the table above and the exercise price was 1/10th of the price set forth in the table. As a result, the number of shares for which the options are exercisable and the exercise price in the above table have been adjusted to reflect the 10-to-1 reverse stock split.

The options were granted on May 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

On May 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $0.68 per share (the trading price for the last business day before the grant date). Therefore, on May 15, 2025, 22,058.82 options were granted to the reporting person.

The options were granted on May 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

On April 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $0.56 per share (the trading price for the last business day before the grant date). Therefore, on April 15, 2025, 26,785.71 options were granted to the reporting person.

The options were granted on April 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

On April 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $0.56 per share (the trading price for the last business day before the grant date). Therefore, on April 15, 2025, 26,785.71 options were granted to the reporting person.

The options were granted on April 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

Reflects the 10-for-1 reverse stock split effected by the Company which became market effective on June 9, 2025.

On April 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $0.56 per share (the trading price for the last business day before the grant date). Therefore, on April 15, 2025, 26,785.71 options were granted to the reporting person. Since the date of issue, the Company effected a 10-for-1 reverse stock split which became market effective on June 9, 2025. The number of options initially issued was 10 times more than the number set forth in the table above and the exercise price was 1/10th of the price set forth in the table. As a result, the number of shares for which the options are exercisable and the exercise price in the above table have been adjusted to reflect the 10-to-1 reverse stock split.

The options were granted on April 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

On March 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.07 per share (the trading price for the last business day before the grant date). Therefore, on March 15, 2025, 14,018.69 options were granted to the reporting person.

The options were granted on March 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

Reflects the 10-for-1 reverse stock split effected by the Company which became market effective on June 9, 2025.

On March 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.07 per share (the trading price for the last business day before the grant date). Therefore, on March 15, 2025, 14,018.69 options were granted to the reporting person. Since the date of issue, the Company effected a 10-for-1 reverse stock split which became market effective on June 9, 2025. The number of options initially issued was 10 times more than the number set forth in the table above and the exercise price was 1/10th of the price set forth in the table. As a result, the number of shares for which the options are exercisable and the exercise price in the above table have been adjusted to reflect the 10-to-1 reverse stock split.

The options were granted on March 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

On March 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.07 per share (the trading price for the last business day before the grant date). Therefore, on March 15, 2025, 14,018.69 options were granted to the reporting person.

The options were granted on March 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

On March 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.07 per share (the trading price for the last business day before the grant date). Therefore, on March 15, 2025, 14,018.69 options were granted to the reporting person.

The options were granted on March 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

On February 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.41 per share (the trading price for the last business day before the grant date). Therefore, on February 15, 2025, 10,638.30 options were granted to the reporting person.

The options were granted on February 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

On February 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.41 per share (the trading price for the last business day before the grant date). Therefore, on February 15, 2025, 10,638.30 options were granted to the reporting person.

The options were granted on February 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

On February 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.41 per share (the trading price for the last business day before the grant date). Therefore, on February 15, 2025, 10,638.30 options were granted to the reporting person.

The options were granted on February 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

Reflects the 10-for-1 reverse stock split effected by the Company which became market effective on June 9, 2025.

On February 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.41 per share (the trading price for the last business day before the grant date). Therefore, on February 15, 2025, 10,638.30 options were granted to the reporting person. Since the date of issue, the Company effected a 10-for-1 reverse stock split which became market effective on June 9, 2025. The number of options initially issued was 10 times more than the number set forth in the table above and the exercise price was 1/10th of the price set forth in the table. As a result, the number of shares for which the options are exercisable and the exercise price in the above table have been adjusted to reflect the 10-to-1 reverse stock split.

The options were granted on February 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

On February 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.41 per share (the trading price for the last business day before the grant date). Therefore, on February 15, 2025, 10,638.30 options were granted to the reporting person.

The options were granted on February 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.